JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area mapk mapk rasgap ras p21'

Search results for: 'research area mapk mapk rasgap ras p21'

A3004 Vemurafenib (PLX4032, RG7204)

9 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
A3189 AS 602801

Summary: Jun Kinase Inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
A8688 TAK-715

Summary: p38 MAPK inhibitor

≥40 mg/mL
A8313 RAF265

Target: Raf|VEGFR

Summary: Multiple intracellular kinases inhibitor

≥25.9 mg/mL
A8245 Sorafenib Tosylate

1 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥31.85 mg/mL
A3009 Sorafenib

2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
A8687 VX-702

Summary: P38α MAPK inhibitor,highly selective and ATP-competitive

insoluble in H2O; ≥20.2 mg/mL
B4620 Losmapimod

1 Citation

Summary: p38 MAPK inhibitor, orally active

insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL
A8689 PD 169316

Target: p38

Summary: P38 MAPK inhibitor

insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
B1285 SB 203580 hydrochloride

Target: p38

Summary: Specific p38-MAPKs inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL